Simplex Trading’s Neumora Therapeutics NMRA Stock Holding History
Bought
Maintained
Sold
Other funds holding NMRA
SL
Simplex Trading's NMRA Position: Q3 2026 in Review
Simplex Trading reduced its Neumora Therapeutics (NMRA) stake by 86% in Q3 2026, selling an estimated $237K and leaving 28,501 shares worth $17K. The position accounts for ﹤0.01% of the portfolio, ranked #7196.
Simplex Trading first reported a position in NMRA in Q1 2024 and has held it in 8 quarters since. The position peaked at $340K in Q2 2026. 127 funds tracked by Wall St. Rank hold NMRA as of Q3 2026.
- Simplex Trading held 28,501 shares of Neumora Therapeutics worth $17K as of Q3 2026.
- Simplex Trading sold 171,309 Neumora Therapeutics shares in Q3 2026, an estimated $237K.
- Neumora Therapeutics made up ﹤0.01% of Simplex Trading's portfolio in Q3 2026, its #7196 holding.
- Simplex Trading first reported a position in Neumora Therapeutics in Q1 2024 and has held it in 8 quarters since.
- Simplex Trading's Neumora Therapeutics position peaked at $340K in Q2 2026.
- 127 funds tracked by Wall St. Rank held Neumora Therapeutics as of Q3 2026.
Based on Simplex Trading's 13F filing for Q3 2026, filed 4 Nov 2026.